Literature DB >> 9413627

The molecular behaviour of cetirizine.

B Testa1, A Pagliara, P A Carrupt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9413627     DOI： 10.1111/j.1365-2222.1997.tb02578.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN： 0954-7894            Impact factor:   5.018


× No keyword cloud information.
  5 in total

1.  Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.

Authors:  Deborah Layton; Lynda Wilton; Andrew Boshier; Victoria Cornelius; Scott Harris; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 2.  Second-generation antihistamines: actions and efficacy in the management of allergic disorders.

Authors:  Larry K Golightly; Leon S Greos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Formulation and Optimization of Sodium Alginate Polymer Film as a Buccal Mucoadhesive Drug Delivery System Containing Cetirizine Dihydrochloride.

Authors:  Krisztián Pamlényi; Katalin Kristó; Orsolya Jójárt-Laczkovich; Géza Regdon
Journal:  Pharmaceutics       Date:  2021-04-26       Impact factor: 6.321

4.  In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al- and Mg/Al-layered double hydroxides.

Authors:  Samer Hasan Hussein-Al-Ali; Mothanna Al-Qubaisi; Mohd Zobir Hussein; Maznah Ismail; Zulkarnain Zainal; Muhammad Nazrul Hakim
Journal:  Int J Mol Sci       Date:  2012-05-16       Impact factor: 6.208

5.  Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells.

Authors:  Samer Hasan; Hussein Al Ali; Mothanna Al-Qubaisi; Mohd Zobir Hussein; Maznah Ismail; Zulkarnain Zainal; Muhammad Nazrul Hakim
Journal:  Int J Nanomedicine       Date:  2012-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.